PL370821A1 - N-ureido-piperidines as antagonists viii for ccr-3 receptor - Google Patents
N-ureido-piperidines as antagonists viii for ccr-3 receptorInfo
- Publication number
- PL370821A1 PL370821A1 PL02370821A PL37082102A PL370821A1 PL 370821 A1 PL370821 A1 PL 370821A1 PL 02370821 A PL02370821 A PL 02370821A PL 37082102 A PL37082102 A PL 37082102A PL 370821 A1 PL370821 A1 PL 370821A1
- Authority
- PL
- Poland
- Prior art keywords
- ccr
- piperidines
- ureido
- antagonists
- viii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33465301P | 2001-11-30 | 2001-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL370821A1 true PL370821A1 (en) | 2005-05-30 |
Family
ID=23308166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02370821A PL370821A1 (en) | 2001-11-30 | 2002-11-25 | N-ureido-piperidines as antagonists viii for ccr-3 receptor |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1453825A1 (en) |
| JP (1) | JP2005515193A (en) |
| KR (1) | KR100652450B1 (en) |
| CN (1) | CN1286831C (en) |
| AR (1) | AR037458A1 (en) |
| AU (1) | AU2002352123A1 (en) |
| BR (1) | BR0214613A (en) |
| CA (1) | CA2467874A1 (en) |
| MX (1) | MXPA04005176A (en) |
| PL (1) | PL370821A1 (en) |
| RU (1) | RU2004120064A (en) |
| WO (1) | WO2003045937A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004041777A2 (en) * | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Heteroarylpiperidine modulators of chemokine receptor activity |
| JP4384635B2 (en) * | 2003-06-30 | 2009-12-16 | 住友化学株式会社 | Asymmetric urea compound and method for producing asymmetric compound by asymmetric conjugate addition reaction using the same |
| WO2005058805A1 (en) * | 2003-12-17 | 2005-06-30 | Sumitomo Chemical Company, Limited | Process for producing optically active amine compound |
| US7635698B2 (en) | 2004-12-29 | 2009-12-22 | Millennium Pharmaceuticals, Inc. | Compounds useful as chemokine receptor antagonists |
| US7880002B2 (en) | 2004-12-29 | 2011-02-01 | Millennium Pharmaceuticals, Inc. | Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists |
| EP2805985A1 (en) * | 2013-05-22 | 2014-11-26 | Sika Technology AG | Polymer containing hydroxysilane and silane groups |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002532427A (en) * | 1998-12-18 | 2002-10-02 | デュポン ファーマシューティカルズ カンパニー | N-ureidoalkylpiperidines as modulators of chemokine receptor activity |
-
2002
- 2002-11-25 KR KR1020047008357A patent/KR100652450B1/en not_active Expired - Fee Related
- 2002-11-25 CN CNB028239784A patent/CN1286831C/en not_active Expired - Fee Related
- 2002-11-25 CA CA002467874A patent/CA2467874A1/en not_active Abandoned
- 2002-11-25 RU RU2004120064/04A patent/RU2004120064A/en not_active Application Discontinuation
- 2002-11-25 WO PCT/EP2002/013218 patent/WO2003045937A1/en not_active Ceased
- 2002-11-25 JP JP2003547387A patent/JP2005515193A/en active Pending
- 2002-11-25 EP EP02787796A patent/EP1453825A1/en not_active Withdrawn
- 2002-11-25 PL PL02370821A patent/PL370821A1/en not_active Application Discontinuation
- 2002-11-25 AU AU2002352123A patent/AU2002352123A1/en not_active Abandoned
- 2002-11-25 BR BR0214613-4A patent/BR0214613A/en not_active IP Right Cessation
- 2002-11-25 MX MXPA04005176A patent/MXPA04005176A/en active IP Right Grant
- 2002-11-28 AR ARP020104581A patent/AR037458A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR037458A1 (en) | 2004-11-10 |
| EP1453825A1 (en) | 2004-09-08 |
| WO2003045937A1 (en) | 2003-06-05 |
| AU2002352123A1 (en) | 2003-06-10 |
| MXPA04005176A (en) | 2004-08-11 |
| KR100652450B1 (en) | 2007-02-28 |
| CN1286831C (en) | 2006-11-29 |
| CN1599733A (en) | 2005-03-23 |
| CA2467874A1 (en) | 2003-06-05 |
| KR20040062665A (en) | 2004-07-07 |
| JP2005515193A (en) | 2005-05-26 |
| RU2004120064A (en) | 2006-01-10 |
| BR0214613A (en) | 2004-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6690001A (en) | Thrombin receptor antagonists | |
| MXPA03005854A (en) | Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists. | |
| IL160918A0 (en) | Himbacine analogues as thrombin receptor antagonists | |
| AU2003261392A8 (en) | M3muscarinic acetylcholine receptor antagonists | |
| AUPR833401A0 (en) | G protein-coupled receptor antagonists | |
| EP1351933A4 (en) | Il-8 receptor antagonists | |
| IL161157A0 (en) | 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists | |
| PL378753A1 (en) | Ccr-3 receptor antagonists | |
| IL164016A0 (en) | Azetidine derivatives as ccr-3 receptor antagonists | |
| EP1359915A4 (en) | Urotensin-ii receptor antagonists | |
| EP1248607A4 (en) | Urotensin-ii receptor antagonists | |
| AU2003267088A8 (en) | Chemokine receptor antagonists as therapeutic agents | |
| PL370799A1 (en) | Aminotetralin derivatives as muscarinic receptor antagonists | |
| IL144299A0 (en) | N-triazolymethyl-piperazine derivatives as neurokinin receptor antagonists | |
| PL362838A1 (en) | Somatostatin antagonists | |
| AU2003240705A1 (en) | Morpholinylmethylureas ccr-3 receptor antagonists | |
| GB0028104D0 (en) | Bombesin receptor antagonists | |
| AU2002226048A1 (en) | Urotensin-ii receptor antagonists | |
| EP1351687A4 (en) | Urotensin-ii receptor antagonists | |
| GB0203412D0 (en) | 5-HT 2B receptor antagonists | |
| PL370821A1 (en) | N-ureido-piperidines as antagonists viii for ccr-3 receptor | |
| GB0028146D0 (en) | Bombesin receptor antagonists | |
| PL370367A1 (en) | Ccr-3 receptor antagonists v | |
| SG131946A1 (en) | Ccr3 receptor antagonists | |
| PL373275A1 (en) | Ccr-3 receptor antagonists vii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |